4.7 Review

GRK mythology: G-protein receptor kinases in cardiovascular disease

Journal

JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 87, Issue 5, Pages 455-463

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00109-009-0450-7

Keywords

G-protein receptor kinases; Adrenergic receptors; Cell signaling; Myocardial infarction; Heart failure

Funding

  1. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087871] Funding Source: NIH RePORTER
  2. NHLBI NIH HHS [R01 HL087871] Funding Source: Medline

Ask authors/readers for more resources

G-protein receptor kinases (GRKs) are indispensable for terminating signaling of G-protein coupled receptors (GPCR) through receptor desensitization and downregulation. Increased neurohormone levels in heart failure and the adverse consequences of constant neurohormonal stimulation suggest an important protective role for mechanisms that desensitize neurohormone receptor responses. For that reason, GRK2, the first GRK identified in the heart, has been extensively studied in heart failure, cardiac hypertrophy, and myocardial infarction. However, our understanding of the roles of GRKs in general, and the differential effects of cardiac receptor phosphorylation by individual cardiac-expressed GRKs, have evolved considerably in the last few years. Here, recent developments are reviewed, with an emphasis on novel GRK functions and signaling pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available